September 13, 2000Etoposide Injection Recalled by
American Pharmaceutical Partners
Park, IL (SafetyAlerts) - The Food
and Drug Administration (FDA) said today that American Pharmaceutical Partners, Inc., is
recalling certain lots of its Etoposide Injection because of misbranding - some vial
cartons are missing printed text.
This is the first public notice of
this Class II
recall issued by FDA.
Etoposide Injection, USP, 20 mg/mL, (100mg/mL), 5 mL multiple dose vial, Rx used
in the management of refractory testicular tumors and small cell lung cancer, and must be
diluted before I.V. infusion.
NDC #63323-104-05. Recall #D-449-0.
Lot #100006 EXP 01/02.
American Pharmaceutical Partners, Inc., Melrose Park, Illinois.
Manufacturer, by letter dated July 27, 2000. Firm-initiated recall ongoing.
12,021 vials were distributed.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.